Skip to main content

Embryology

Volume 715: debated on Monday 14 December 2009

Questions

Asked by

To ask Her Majesty's Government further to the Written Answer by Lord Drayson on 3 December (WA 67), who bore the additional cost to allow the completion of the planned research if it was not borne by the Medical Research Council (MRC); and why MRC approval was a factor if no further MRC funding was involved. [HL677]

The one-year extension awarded to the University of Newcastle for the project “Improving the efficiency of human somatic cell nuclear transfer” involves no additional costs. The Medical Research Council (MRC) sometimes grants extensions to the duration of research projects, at no additional cost to the MRC, to allow the completion of the planned research. Such a time-only extension is the standard mechanism employed by the MRC for allowing grants to fulfil their original objectives. An extension to the duration of a project allows the host institution to reallocate the original funding awarded by the MRC over the extended time period agreed. Formal approval is required for all proposed changes to the duration of an MRC award.

Asked by

To ask Her Majesty's Government further to the Written Answer by Lord Drayson on 3 December (WA 67), what were the original objectives; why they were not fulfilled within the original timescale; and how the additional time will meet the objectives unless research costs are met. [HL678]

I refer the noble Lord to my previous Answers of 19 May 2009 (col. WA 290) and 5 May 2009 (col. 95W), in which the original objectives are outlined. I will ask the chief executive of the Medical Research Council to write to the noble Lord with further information on the progress of this ongoing study. A copy of his letter will be placed in the Library of the House.